R. Drasga

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

L. Einhorn, F. Greco, P. Loehrer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.

L. Einhorn, P. Loehrer, S. Williams, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fertility after chemotherapy for testicular cancer.

L. Einhorn, S. Williams, R. Drasga, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.

L. Einhorn, S. Williams, R. Birch, 1987, Cancer treatment reports.

The chemotherapy of testicular cancer

L. Einhorn, R. Drasga, Stephen D. Williams, 1982 .

The chemotherapy of testicular cancer

L. Einhorn, S. Williams, R. Drasga, 1982, CA: a cancer journal for clinicians.

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone‐refractory prostatic cancer: A hoosier oncology group study

L. Einhorn, S. Saxman, R. Drasga, 1992, Cancer.

Why oncologists should support single-payer national health insurance.

L. Einhorn, R. Drasga, 2014, Journal of oncology practice.

Why oncologists should support single-payer national health insurance.

L. Einhorn, R. Drasga, 2014, Journal of oncology practice.